Forte Biosciences Inc. (FBRX)
NASDAQ: FBRX
· Real-Time Price · USD
11.30
0.48 (4.44%)
At close: Aug 15, 2025, 12:53 PM
4.44% (1D)
| Bid | 11.02 |
| Market Cap | 138.02M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -43.71M |
| EPS (ttm) | -9.51 |
| PE Ratio (ttm) | -1.19 |
| Forward PE | -3.18 |
| Analyst | Buy |
| Ask | 11.49 |
| Volume | 7,377 |
| Avg. Volume (20D) | 102,467 |
| Open | 10.99 |
| Previous Close | 10.82 |
| Day's Range | 10.99 - 11.45 |
| 52-Week Range | 4.11 - 28.68 |
| Beta | 2.91 |
About FBRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FBRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FBRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-25.26%
Forte Biosciences shares are trading lower after t...
Unlock content with
Pro Subscription
1 month ago
+11.05%
Forte Biosciences shares are trading lower after the company announced a proposed public offering.
1 month ago · businesswire.com
Forte Biosciences Announces Pricing of $75 Million Public OfferingDALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a publ...
